Skip to main content

Advances in Therapy

Ausgabe 3/2024

Inhalt (24 Artikel)

Commentary

Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy

Arun K. Mankan, Nagender Mankan, Begona de las Heras, Shakti H. Ramkissoon, Olga Bodriagova, Laura Vidal, Enrique Grande, Kamal S. Saini

Open Access Commentary

Autologous Skin Cell Suspension for Full-Thickness Skin Defect Reconstruction: Current Evidence and Health Economic Expectations

Steven A. Kahn, Jeffrey E. Carter, Shelby Wilde, Aleisha Chamberlain, Thomas P. Walsh, Jeremiah A. Sparks

Open Access Summary of Research

Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study

Emma Guttman-Yassky, Eric L. Simpson, Kristian Reich, Kenji Kabashima, Ken Igawa, Tetsuya Suzuki, Hirotaka Mano, Takeshi Matsui, Ehsanollah Esfandiari, Masutaka Furue

Open Access Review

The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults

Jakob Langer, Verna L. Welch, Mary M. Moran, Alejandro Cane, Santiago M. C. Lopez, Amit Srivastava, Ashley Enstone, Amy Sears, Kristen Markus, Maria Heuser, Rachel Kewley, Isabelle Whittle

Review

Artificial Intelligence in Liver Diseases: Recent Advances

Feifei Lu, Yao Meng, Xiaoting Song, Xiaotong Li, Zhuang Liu, Chunru Gu, Xiaojie Zheng, Yi Jing, Wei Cai, Kanokwan Pinyopornpanish, Andrea Mancuso, Fernando Gomes Romeiro, Nahum Méndez-Sánchez, Xingshun Qi

Open Access Original Research

A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants

Hong Tang, Francesca Civoli, Suzanna Tatarewicz, Nathalie Vandenkoornhuyse, Barbara Finck

Open Access Original Research

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

Laurent Kodjikian, Lluís Arias Barquet, András Papp, Peter J. Kertes, Edoardo Midena, Jan Ernest, Rufino Silva, Thomas Schmelter, Tobias Niesen, Sergio Leal

Open Access Original Research

Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)

Richard Langford, Esther M. Pogatzki-Zahn, Adelaida Morte, Mariano Sust, Jesús Cebrecos, Anna Vaqué, Esther Ortiz, James Fettiplace, Shola Adeyemi, José Luis López-Cedrún, Socorro Bescós, Neus Gascón, Carlos Plata-Salamán

Open Access Original Research

Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Amy S. Paller, Andreas Pinter, Lara Wine Lee, Roland Aschoff, Jacek Zdybski, Christina Schnopp, Amy Praestgaard, Ashish Bansal, Brad Shumel, Randy Prescilla, Mike Bastian

Open Access Original Research

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Joan Barberà, Pavel Jansa, Elizabeth Klings, Arsen Ristić, Anne Keogh, Derek Solum, Youlan Rao, Rob Grover, Isil Saib, Namita Sood

Open Access Original Research

Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study

Amita Ketkar, Vincent Willey, Lisa Glasser, Casey Dobie, Cachet Wenziger, Chia-Chen Teng, Christine Dube, Sunny Hirpara, Dennis Cunningham, Monica Verduzco-Gutierrez

Open Access Original Research

Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE

Audrey Muller, Pilar Escribano-Subias, Catarina C. Fernandes, Martina Fontana, Tobias J. Lange, Stefan Söderberg, Sean Gaine

Open Access Original Research

Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study

Mohammed AlHarbi, Abdullah Othman, Ahmed Ali Nahari, Ahmed Hamdan Al-Jedai, Daniel Cuadras, Faisal Almalky, Fayez AlAzmi, Hajer Yousef Almudaiheem, Hamad AlShubrumi, Hameed AlSwat, Homaid AlSahafi, Kamelia Sindi, Khadija Basaikh, Majed AlQahtani, Mark Lamotte, Moataz Yahia, Mohamed El-Khedr Hassan, Mohammed AlMutlaq, Mohammed AlRoaly, Somaya AlZelaye, Zein AlGhamdi

Open Access Original Research

Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

Navdeep Tangri, Anjay Rastogi, Cassandra Nekeman-Nan, Lai San Hong, Asuka Ozaki, Stefan Franzén, Tadashi Sofue

Open Access Original Research

Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI)

Haiting Wu, Hong Cheng, Caili Wang, Li Yao, Shuguang Qin, Li Zuo, Zhao Hu, Chun Zhang, Yiqing Wu, Alexis Hofherr, Katie Mohan, Stephen Rush, Xuemei Li

Open Access Original Research

Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study

Michael Lehrke, Anja Vogt, Volker Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N. Dhalwani, Kausik K. Ray

Open Access Original Research

Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials

Sven C. van Dijkman, Arzu Yorgancıoğlu, Ian Pavord, Guy Brusselle, Paulo M. Pitrez, Sean Oosterholt, Sourabh Fumali, Anurita Majumdar, Oscar Della Pasqua

Open Access Original Research

Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis

Andrew Ip, Alex Mutebi, Tongsheng Wang, Monika Jun, Anupama Kalsekar, Fernando Rivas Navarro, Anthony Wang, Rajesh Kamalakar, Mariana Sacchi, Brian Elliott

Open Access Original Research

Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)

Meredith McCormack, Rosirene Paczkowski, Noelle N. Gronroos, Stephen G. Noorduyn, Lydia Lee, Phani Veeranki, Mary G. Johnson, Emmeline Igboekwe, Kristin Kahle-Wrobleski, Reynold Panettieri

Open Access Original Research

The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia

David Price, Christine Jenkins, Kerry Hancock, Rebecca Vella, Florian Heraud, Porsche Le Cheng, Ruth Murray, Maarten Beekman, Sinthia Bosnic-Anticevich, Fabio Botini, Victoria Carter, Angelina Catanzariti, Joe Doan, Kirsty Fletton, Ata Kichkin, Thao Le, Chantal Le Lievre, Chi Ming Lau, Dominique Novic, John Pakos, Kanchanamala Ranasinghe, Alexander Roussos, Josephine Samuel-King, Anita Sharma, Deb Stewart, Bruce Willet, Eric Bateman, Rob Campbell, Ying Liu, Nicole O’Sullivan, Ondrej Rejda, Lisa Sugg, Steph James, Kiran Dhillon, Sophie Jones

Open Access Original Research

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study

Eiichiro Yamamoto, Hiroki Usuku, Daisuke Sueta, Satoru Suzuki, Taishi Nakamura, Kunihiko Matsui, Kenichi Matsushita, Tomoko Iwasaki, Naritsugu Sakaino, Toshihiko Sakanashi, Kazuto Hirayama, Hirofumi Kurokawa, Koichi Kikuta, Nobuyasu Yamamoto, Koji Sato, Takanori Tokitsu, Takashi Taguchi, Kazuhito Shiosakai, Kotaro Sugimoto, Kenichi Tsujita

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.